PhRMA Sues Trump Administration Over Medicare Drug Price Pilot Program
Source Summary
The Pharmaceutical Research and Manufacturers of America (PhRMA), the brand drug industry's main trade group, has filed a lawsuit against the Trump administration challenging a pilot program that ties Medicare drug prices to those in peer countries. The lawsuit contests the administration's policy approach to lowering drug costs through international price benchmarking.
Why it matters
This lawsuit represents a direct legal challenge to a Trump administration policy aimed at reducing Medicare drug costs, a central healthcare cost-control initiative with implications for drug pricing regulation and industry compliance.
